Corticosteroid injection in the treatment of a huge-size central giant cell granuloma in children: A case report

IF 0.6 Q4 DENTISTRY, ORAL SURGERY & MEDICINE Pediatric Dental Journal Pub Date : 2024-01-03 DOI:10.1016/j.pdj.2023.12.005
Serap Keskin Tunç , Nihat Efe , Ümit Ertaş
{"title":"Corticosteroid injection in the treatment of a huge-size central giant cell granuloma in children: A case report","authors":"Serap Keskin Tunç ,&nbsp;Nihat Efe ,&nbsp;Ümit Ertaş","doi":"10.1016/j.pdj.2023.12.005","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Central giant cell granulomas (CGCGs) of the jaw are benign intraosseous and </span>osteolytic lesions<span>. Their clinical presentation includes atypical aggressive lesions that cause severe damage early in life, and aggressive treatment is necessary in most cases to prevent recurrence. </span></span>Curettage<span><span> is the most preferred therapy, but in recent years, conservative therapy is also commonly used. Corticosteroid injection treatment, a conservative method, was planned for a developing male patient with difficulty in diagnosis and treatment due to the complications of resection. After clinical and radiologic evaluation of the patient, incisional biopsy was performed and the diagnosis of SDHG was made. The patient was treated with intralesional corticosteroids once a week for eight weeks. Since the patient's treatment was interrupted for 2 months due to the Covid-19 outbreak, 2 doses of intralesional corticosteroid (Sinakort-A 40 mg) were administered and the patient was followed up. At 12 months, clinical and panoramic radiographic examination revealed no pathologic findings related to the lesion. In this article, we report a </span>pediatric case of giant CGCG successfully treated with intralesional corticosteroid injection.</span></p></div>","PeriodicalId":19977,"journal":{"name":"Pediatric Dental Journal","volume":"34 1","pages":"Pages 49-54"},"PeriodicalIF":0.6000,"publicationDate":"2024-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Dental Journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0917239423000629","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Central giant cell granulomas (CGCGs) of the jaw are benign intraosseous and osteolytic lesions. Their clinical presentation includes atypical aggressive lesions that cause severe damage early in life, and aggressive treatment is necessary in most cases to prevent recurrence. Curettage is the most preferred therapy, but in recent years, conservative therapy is also commonly used. Corticosteroid injection treatment, a conservative method, was planned for a developing male patient with difficulty in diagnosis and treatment due to the complications of resection. After clinical and radiologic evaluation of the patient, incisional biopsy was performed and the diagnosis of SDHG was made. The patient was treated with intralesional corticosteroids once a week for eight weeks. Since the patient's treatment was interrupted for 2 months due to the Covid-19 outbreak, 2 doses of intralesional corticosteroid (Sinakort-A 40 mg) were administered and the patient was followed up. At 12 months, clinical and panoramic radiographic examination revealed no pathologic findings related to the lesion. In this article, we report a pediatric case of giant CGCG successfully treated with intralesional corticosteroid injection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
皮质类固醇注射治疗儿童巨大中央巨细胞肉芽肿:病例报告
颌骨中央巨细胞肉芽肿(CGCGs)是骨内良性溶骨性病变。其临床表现包括不典型的侵袭性病变,会在生命早期造成严重损害,大多数病例都需要积极治疗以防止复发。刮宫术是最理想的治疗方法,但近年来保守疗法也很常用。一名发育中的男性患者由于切除术的并发症而导致诊断和治疗困难,因此计划采用皮质类固醇注射治疗这种保守方法。在对患者进行临床和放射学评估后,进行了切口活检,诊断为 SDHG。患者接受了皮质类固醇激素治疗,每周一次,持续八周。由于 Covid-19 的爆发,患者的治疗中断了 2 个月,因此又注射了 2 次皮质类固醇(Sinakort-A 40 毫克),并对患者进行了随访。12 个月后,临床和全景影像学检查均未发现与病变相关的病理结果。在这篇文章中,我们报告了一例儿科巨型CGCG病例,该病例通过局部注射皮质类固醇获得了成功治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pediatric Dental Journal
Pediatric Dental Journal DENTISTRY, ORAL SURGERY & MEDICINE-
CiteScore
1.40
自引率
0.00%
发文量
24
审稿时长
26 days
期刊最新文献
Evaluation of the combined effect of type of instrumentation systems and obturating materials on the outcome of pulpectomized primary molars-A comparative randomized clinical trial Relationship between early childhood caries and parents' knowledge and attitudes towards primary teeth High-performance silica-containing professional mechanical tooth-cleaning paste that effectively adsorbs pigments Oral health practices and challenges facing parents of autistic children in the Western Cape (2021) Postoperative pain after vital pulp therapy: A review of its characteristics and associated factors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1